Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1991 1
1992 3
1993 4
1994 4
1995 2
1997 1
1998 6
1999 10
2000 1
2001 4
2003 6
2004 8
2005 5
2006 8
2007 6
2008 3
2009 1
2010 1
2011 4
2012 1
2014 1
2015 2
2016 2
2017 4
2018 2
2019 3
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
Structural basis of species-selective antagonist binding to the succinate receptor.
Haffke M, Fehlmann D, Rummel G, Boivineau J, Duckely M, Gommermann N, Cotesta S, Sirockin F, Freuler F, Littlewood-Evans A, Kaupmann K, Jaakola VP. Haffke M, et al. Among authors: kaupmann k. Nature. 2019 Oct;574(7779):581-585. doi: 10.1038/s41586-019-1663-8. Epub 2019 Oct 23. Nature. 2019. PMID: 31645725
Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors.
Hoegenauer K, Kallen J, Jiménez-Núñez E, Strang R, Ertl P, Cooke NG, Hintermann S, Voegtle M, Betschart C, McKay DJJ, Wagner J, Ottl J, Beerli C, Billich A, Dawson J, Kaupmann K, Streiff M, Gobeau N, Harlfinger S, Stringer R, Guntermann C. Hoegenauer K, et al. Among authors: kaupmann k. J Med Chem. 2019 Dec 12;62(23):10816-10832. doi: 10.1021/acs.jmedchem.9b01291. Epub 2019 Dec 3. J Med Chem. 2019. PMID: 31729873
Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure.
Velcicky J, Wilcken R, Cotesta S, Janser P, Schlapbach A, Wagner T, Piechon P, Villard F, Bouhelal R, Piller F, Harlfinger S, Stringer R, Fehlmann D, Kaupmann K, Littlewood-Evans A, Haffke M, Gommermann N. Velcicky J, et al. Among authors: kaupmann k. J Med Chem. 2020 Sep 10;63(17):9856-9875. doi: 10.1021/acs.jmedchem.0c01020. Epub 2020 Aug 28. J Med Chem. 2020. PMID: 32856916
Molecular pharmacology of somatostatin-receptor subtypes.
Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lübbert H. Bruns C, et al. Among authors: kaupmann k. Ann N Y Acad Sci. 1994 Sep 15;733:138-46. doi: 10.1111/j.1749-6632.1994.tb17263.x. Ann N Y Acad Sci. 1994. PMID: 7978861 Review. No abstract available.
GABAB receptors: drugs meet clones.
Bettler B, Kaupmann K, Bowery N. Bettler B, et al. Among authors: kaupmann k. Curr Opin Neurobiol. 1998 Jun;8(3):345-50. doi: 10.1016/s0959-4388(98)80059-7. Curr Opin Neurobiol. 1998. PMID: 9687348 Review.
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations.
Guntermann C, Piaia A, Hamel ML, Theil D, Rubic-Schneider T, Del Rio-Espinola A, Dong L, Billich A, Kaupmann K, Dawson J, Hoegenauer K, Orain D, Hintermann S, Stringer R, Patel DD, Doelemeyer A, Deurinck M, Schümann J. Guntermann C, et al. Among authors: kaupmann k. JCI Insight. 2017 Mar 9;2(5):e91127. doi: 10.1172/jci.insight.91127. JCI Insight. 2017. PMID: 28289717 Free PMC article.
Ligands for the isolation of GABA(B) receptors [corrected].
Froestl W, Bettler B, Bittiger H, Heid J, Kaupmann K, Mickel SJ, Strub D. Froestl W, et al. Among authors: kaupmann k. Neuropharmacology. 1999 Nov;38(11):1641-6. doi: 10.1016/s0028-3908(99)00134-3. Neuropharmacology. 1999. PMID: 10587079 Review.
91 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page